|
| |
| | 67529 | | 28.06.2021 | | Novartis Pharma Schweiz AG | | | | | | 13.09.2028 | | | | | | 01.99. | | | | 01.99. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | ZOLGENSMA | Solution for Infusion | (Onasemnogenum Abeparvovecum 2 ) | M09AX09 | CI | 02 | Zolgensma | | (Onasemnogenum Abeparvovecum 20000000 Mio U) | | |
|
|
|